Conventional chemical syntheses fail at completing peptides with extreme properties correctly. Some peptides crumble or repel their amino acid building blocks during the construction of the amino acid chain.
Biosynthesis overcomes these problems and allows for the production of complex peptides. The mk2 Biotechnologies process is designed to circumvent purification troubles that occur in both state of the art chemical and biological syntheses. It is based on the well-known recombinant synthesis route successfully applied for production of long-chained proteins, though includes several groundbreaking improvements making the technology fully applicable to short and medium length peptide classes.
- Super Purity: Our process allows the production of peptides with purities >99.9% which can be further increased for individual needs. It is not necessary for the customer to provide inhouse purification know-how and infrastructure.
Arbitrary Sequences and Properties: The synthesis of any amino acid sequence is our peculiar strenght. We can provide peptides with any charge, polarity, hydrophobicity etc.
Ecofriendly: The synthesis of peptides by mk2 Biotechnologies is highly environemntal friendly since no toxic waste is produced and most of the biological side products are fully recyclable.
Flexible Chain Length: mk2 Biotechnologies can provide individually designed peptides including intermediate chain legnths of 25-100 amino acids.
Scalability: Our process is highly scalable and automatable. We therefore can supply peptides for bigger sized applications at constant high quality.
Functionalization: The process offers the possibility to functionalize our products with several kinds of biological or chemical functional groups like photoluminescent markers, clickable groups and others.
In the latest 50 years the worldwide technology went through an originally unimaginable development. Though, the major technological improvements were achieved in the field of IT and digitalization, while other fields of technology slowly passivated. While the social challenges arising from the growing world population and the simultaneous demand of wealth and prosperity in every single corner of our world, the stagnating technology fields were unable to find new and more effective solutions. Therefore, many actual challenges are faced by the “more-approach”. More surgeries, more medications, more fertilizers; the list appears to be infinite. Unfortunately, this approach does not simply get to grips with the symptoms, but at the same time worsens their origin: Ecosystems and every single part of it become more and more sensitive to any external influence and loose more and more their natural buffer capabilities. This results into an exponential demand of state-of the-art solutions leading into a vicious circle. Our modern technologies in many cases actually do not provide solutions anymore, they rather relocate the critical point of breakdown to future times.
We at mk2 Biotechnologies are strongly convinced, that our novel peptide synthesis technology has the potential to tackle parts of the major social challenges and provide solutions for a known and yet unknown demand for chemical and/or biological active substances. We believe to contribute significantly e.g. in the reduction of the “agricultural chemotherapy” with target-oriented crop protection and the prevention of antibiotic resistances in a broad field of applications. We furthermore will provide a backbone for modern medicine in its battle against widespread diseases by providing novel active ingredients.